Taurine in Peripartum Cardiomyopathy

Taurine as an adjunct for early left ventricular recovery in peripartum cardiomyopathy

Completed

Looking for future studies?

Key information

Conditions

Peripartum Cardiomyopathy Cardiomyopathies Cardiovascular Diseases Female Urogenital Diseases and Pregnancy Complications Heart Diseases Pregnancy Complications Pregnancy Complications, Cardiovascular Urogenital Diseases

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Ain Shams University Maternity Hospital

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Peripartum Cardiomyopathy

Exclusion criteria

Other identifiable cause for heart failure
low LVEF ≤ 25%
sepsis
autoimmune disease
severe chronic disease
malignancy

Treatment and study plan

Taurine Solution

Drug

Taurine Solution

Normal saline

Dietary Supplement

Normal Saline

Primary outcomes

improvement of the left ventricular ejection fraction >10 %

Time frame: 1 week

improvement of the left ventricular ejection fraction >10 %

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Taurine for Early Left Ventricular Recovery in Peripartum Cardiomyopathy

Important dates

Study start: 2015
Primary completion: 2019
Study completion: 2020
First posted: Apr 8, 2019
Registry last updated: Jan 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed